General Motors Co — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that General Motors Co filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $185.02B | Jan 27, 2026 |
| FY2025 | Dec 31, 2024 | $187.44B | Jan 27, 2026 |
| FY2025 | Dec 31, 2023 | $171.84B | Jan 27, 2026 |
| FY2024 | Dec 31, 2022 | $156.74B | Jan 28, 2025 |
| FY2023 | Dec 31, 2021 | $127.00B | Jan 30, 2024 |
| FY2022 | Dec 31, 2020 | $122.49B | Jan 31, 2023 |
| FY2019 | Dec 31, 2019 | $30.83B | Feb 5, 2020 |
| FY2019 | Sep 30, 2019 | $35.47B | Feb 5, 2020 |
| FY2019 | Jun 30, 2019 | $36.06B | Feb 5, 2020 |
| FY2019 | Mar 31, 2019 | $34.88B | Feb 5, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $167.97B | Jan 27, 2026 |
| FY2025 | Dec 31, 2024 | $171.61B | Jan 27, 2026 |
| FY2025 | Dec 31, 2023 | $157.66B | Jan 27, 2026 |
| FY2024 | Dec 31, 2022 | $143.98B | Jan 28, 2025 |
| FY2023 | Dec 31, 2021 | $113.59B | Jan 30, 2024 |
| FY2022 | Dec 31, 2020 | $108.67B | Jan 31, 2023 |
| FY2021 | Dec 31, 2019 | $122.70B | Feb 2, 2022 |
| FY2020 | Dec 31, 2018 | $133.05B | Feb 10, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $133.45B | Feb 6, 2018 |
| FY2017 | Dec 31, 2016 | $140.21B | Feb 6, 2018 |
| FY2017 | Dec 31, 2015 | $129.86B | Feb 6, 2018 |
| FY2016 | Dec 31, 2014 | $151.09B | Feb 7, 2017 |
| FY2015 | Dec 31, 2013 | $152.09B | Feb 3, 2016 |
| FY2014 | Dec 31, 2012 | $150.30B | Feb 4, 2015 |
| FY2013 | Dec 31, 2011 | $148.87B | Feb 6, 2014 |
| FY2012 | Dec 31, 2010 | $135.31B | Feb 15, 2013 |
| FY2011 | Dec 31, 2009 | $57.47B | Feb 27, 2012 |
| FY2011 | Jul 9, 2009 | $47.12B | Feb 27, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | ($3.14B) | Feb 15, 2013 |
| FY2012 | Sep 30, 2012 | $4.33B | Feb 15, 2013 |
| FY2012 | Jun 30, 2012 | $4.45B | Feb 15, 2013 |
| FY2012 | Mar 31, 2012 | $4.42B | Feb 15, 2013 |
| FY2011 | Dec 31, 2011 | $4.42B | Feb 27, 2012 |
| FY2011 | Sep 30, 2011 | $4.59B | Feb 27, 2012 |
| FY2011 | Jun 30, 2011 | $5.25B | Feb 27, 2012 |
| FY2011 | Mar 31, 2011 | $4.21B | Feb 27, 2012 |
| FY2011 | Dec 31, 2010 | $3.58B | Feb 27, 2012 |
| FY2011 | Sep 30, 2010 | $4.47B | Feb 27, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.70B | Jan 27, 2026 |
| FY2025 | Dec 31, 2024 | $6.01B | Jan 27, 2026 |
| FY2025 | Dec 31, 2023 | $10.13B | Jan 27, 2026 |
| FY2024 | Dec 31, 2022 | $9.93B | Jan 28, 2025 |
| FY2023 | Dec 31, 2021 | $10.02B | Jan 30, 2024 |
| FY2022 | Dec 31, 2020 | $6.43B | Jan 31, 2023 |
| FY2019 | Dec 31, 2019 | ($194.00M) | Feb 5, 2020 |
| FY2019 | Sep 30, 2019 | $2.35B | Feb 5, 2020 |
| FY2019 | Jun 30, 2019 | $2.42B | Feb 5, 2020 |
| FY2019 | Mar 31, 2019 | $2.16B | Feb 5, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.91B | Jan 27, 2026 |
| FY2025 | Dec 31, 2024 | $12.78B | Jan 27, 2026 |
| FY2025 | Dec 31, 2023 | $9.30B | Jan 27, 2026 |
| FY2024 | Dec 31, 2022 | $10.32B | Jan 28, 2025 |
| FY2023 | Dec 31, 2021 | $9.32B | Jan 30, 2024 |
| FY2022 | Dec 31, 2020 | $6.63B | Jan 31, 2023 |
| FY2021 | Dec 31, 2019 | $5.48B | Feb 2, 2022 |
| FY2020 | Dec 31, 2018 | $4.45B | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $8.66B | Feb 5, 2020 |
| FY2018 | Dec 31, 2016 | $8.69B | Feb 6, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $7.20B | Feb 6, 2014 |
| FY2012 | Dec 31, 2012 | $7.37B | Feb 15, 2013 |
| FY2011 | Dec 31, 2011 | $8.12B | Feb 27, 2012 |
| FY2011 | Dec 31, 2010 | $6.96B | Feb 27, 2012 |
| FY2011 | Dec 31, 2009 | $3.03B | Feb 27, 2012 |
| FY2011 | Jul 9, 2009 | $3.02B | Feb 27, 2012 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $8.55B | Feb 2, 2022 |
| FY2021 | Dec 31, 2020 | $7.04B | Feb 2, 2022 |
| FY2021 | Dec 31, 2019 | $8.49B | Feb 2, 2022 |
| FY2020 | Dec 31, 2018 | $9.65B | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $9.57B | Feb 5, 2020 |
| FY2018 | Dec 31, 2016 | $10.35B | Feb 6, 2019 |
| FY2017 | Dec 31, 2015 | $11.89B | Feb 6, 2018 |
| FY2016 | Dec 31, 2014 | $12.16B | Feb 7, 2017 |
| FY2015 | Dec 31, 2013 | $12.38B | Feb 3, 2016 |
| FY2014 | Dec 31, 2012 | $14.03B | Feb 4, 2015 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.87B | Jan 27, 2026 |
| FY2025 | Dec 31, 2024 | $20.13B | Jan 27, 2026 |
| FY2025 | Dec 31, 2023 | $20.93B | Jan 27, 2026 |
| FY2024 | Dec 31, 2022 | $16.04B | Jan 28, 2025 |
| FY2023 | Dec 31, 2021 | $15.19B | Jan 30, 2024 |
| FY2022 | Dec 31, 2020 | $16.67B | Jan 31, 2023 |
| FY2021 | Dec 31, 2019 | $15.02B | Feb 2, 2022 |
| FY2020 | Dec 31, 2018 | $15.26B | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $17.33B | Feb 5, 2020 |
| FY2018 | Dec 31, 2016 | $16.61B | Feb 6, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.30B | Jan 27, 2026 |
| FY2025 | Dec 31, 2024 | $10.83B | Jan 27, 2026 |
| FY2025 | Dec 31, 2023 | $10.97B | Jan 27, 2026 |
| FY2024 | Dec 31, 2022 | $9.24B | Jan 28, 2025 |
| FY2023 | Dec 31, 2021 | $7.51B | Jan 30, 2024 |
| FY2022 | Dec 31, 2020 | $5.30B | Jan 31, 2023 |
| FY2021 | Dec 31, 2019 | $7.59B | Feb 2, 2022 |
| FY2020 | Dec 31, 2018 | $8.76B | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $8.45B | Feb 5, 2020 |
| FY2018 | Dec 31, 2016 | $8.38B | Feb 6, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $281.28B | Jan 27, 2026 |
| FY2025 | Dec 31, 2024 | $279.76B | Jan 27, 2026 |
| FY2025 | Dec 31, 2023 | $273.06B | Jan 27, 2026 |
| FY2024 | Dec 31, 2022 | $264.04B | Jan 28, 2025 |
| FY2023 | Dec 31, 2021 | $244.72B | Jan 30, 2024 |
| FY2022 | Dec 31, 2020 | $235.19B | Jan 31, 2023 |
| FY2021 | Dec 31, 2019 | $228.04B | Feb 2, 2022 |
| FY2020 | Dec 31, 2018 | $227.34B | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $212.48B | Feb 5, 2020 |
| FY2018 | Dec 31, 2016 | $221.69B | Feb 6, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $218.12B | Jan 27, 2026 |
| FY2025 | Dec 31, 2024 | $214.17B | Jan 27, 2026 |
| FY2024 | Dec 31, 2023 | $204.76B | Jan 28, 2025 |
| FY2023 | Dec 31, 2022 | $191.75B | Jan 30, 2024 |
| FY2022 | Dec 31, 2021 | $178.90B | Jan 31, 2023 |
| FY2021 | Dec 31, 2020 | $185.52B | Feb 2, 2022 |
| FY2020 | Dec 31, 2019 | $182.08B | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $184.56B | Feb 5, 2020 |
| FY2018 | Dec 31, 2017 | $176.28B | Feb 6, 2019 |
| FY2017 | Dec 31, 2016 | $177.62B | Feb 6, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $61.12B | Jan 27, 2026 |
| FY2025 | Dec 31, 2024 | $63.07B | Jan 27, 2026 |
| FY2024 | Dec 31, 2023 | $64.29B | Jan 28, 2025 |
| FY2023 | Dec 31, 2022 | $67.79B | Jan 30, 2024 |
| FY2022 | Dec 31, 2021 | $59.74B | Jan 31, 2023 |
| FY2021 | Dec 31, 2020 | $45.03B | Feb 2, 2022 |
| FY2020 | Dec 31, 2019 | $41.79B | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $38.86B | Feb 5, 2020 |
| FY2018 | Dec 31, 2017 | $35.00B | Feb 6, 2019 |
| FY2017 | Dec 31, 2016 | $43.84B | Feb 6, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.90B | Jan 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.90B | Jan 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.90B | Jan 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.90B | Jan 30, 2024 |
| FY2022 | Dec 31, 2021 | $1.90B | Jan 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.90B | Feb 2, 2022 |
| FY2020 | Dec 31, 2019 | $1.90B | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $1.90B | Feb 5, 2020 |
| FY2018 | Dec 31, 2017 | $1.90B | Feb 6, 2019 |
| FY2017 | Dec 31, 2016 | $1.90B | Feb 6, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $51.52B | Jan 27, 2026 |
| FY2025 | Dec 31, 2024 | $53.47B | Jan 27, 2026 |
| FY2024 | Dec 31, 2023 | $55.39B | Jan 28, 2025 |
| FY2023 | Dec 31, 2022 | $49.25B | Jan 30, 2024 |
| FY2022 | Dec 31, 2021 | $41.94B | Jan 31, 2023 |
| FY2021 | Dec 31, 2020 | $31.96B | Feb 2, 2022 |
| FY2020 | Dec 31, 2019 | $26.86B | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $22.32B | Feb 5, 2020 |
| FY2018 | Jan 1, 2018 | $16.58B | Feb 6, 2019 |
| FY2018 | Dec 31, 2017 | $17.63B | Feb 6, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.95B | Jan 27, 2026 |
| FY2025 | Dec 31, 2024 | $19.87B | Jan 27, 2026 |
| FY2024 | Dec 31, 2023 | $18.85B | Jan 28, 2025 |
| FY2023 | Dec 31, 2022 | $19.15B | Jan 30, 2024 |
| FY2022 | Dec 31, 2021 | $20.07B | Jan 31, 2023 |
| FY2021 | Dec 31, 2020 | $19.99B | Feb 2, 2022 |
| FY2020 | Dec 31, 2019 | $19.07B | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $20.84B | Feb 5, 2020 |
| FY2018 | Dec 31, 2017 | $15.51B | Feb 6, 2019 |
| FY2017 | Dec 31, 2016 | $12.57B | Feb 6, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Jan 27, 2026 |
| FY2025 | Dec 31, 2024 | 6 | Jan 27, 2026 |
| FY2025 | Dec 31, 2023 | 7 | Jan 27, 2026 |
| FY2024 | Dec 31, 2022 | 6 | Jan 28, 2025 |
| FY2023 | Dec 31, 2021 | 6 | Jan 30, 2024 |
| FY2022 | Dec 31, 2020 | 4 | Jan 31, 2023 |
| FY2021 | Dec 31, 2019 | 4 | Feb 2, 2022 |
| FY2020 | Dec 31, 2018 | 5 | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | (2) | Feb 5, 2020 |
| FY2016 | Dec 31, 2016 | 1 | Feb 7, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Jan 27, 2026 |
| FY2025 | Dec 31, 2024 | 6 | Jan 27, 2026 |
| FY2025 | Dec 31, 2023 | 7 | Jan 27, 2026 |
| FY2024 | Dec 31, 2022 | 6 | Jan 28, 2025 |
| FY2023 | Dec 31, 2021 | 6 | Jan 30, 2024 |
| FY2022 | Dec 31, 2020 | 4 | Jan 31, 2023 |
| FY2021 | Dec 31, 2019 | 4 | Feb 2, 2022 |
| FY2020 | Dec 31, 2018 | 5 | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | (2) | Feb 5, 2020 |
| FY2016 | Dec 31, 2016 | 1 | Feb 7, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 904.00M | Jan 27, 2026 |
| FY2025 | Dec 31, 2024 | 995.00M | Jan 27, 2026 |
| FY2024 | Dec 31, 2023 | 1.20B | Jan 28, 2025 |
| FY2023 | Dec 31, 2022 | 1.40B | Jan 30, 2024 |
| FY2022 | Dec 31, 2021 | 1.50B | Jan 31, 2023 |
| FY2021 | Dec 31, 2020 | 1.40B | Feb 2, 2022 |
| FY2020 | Dec 31, 2019 | 1.40B | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | 1.40B | Feb 5, 2020 |
| FY2018 | Dec 31, 2017 | 1.40B | Feb 6, 2019 |
| FY2017 | Dec 31, 2016 | 1.50B | Feb 6, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $1.93B | Feb 4, 2015 |
| FY2014 | Dec 31, 2013 | $0 | Feb 4, 2015 |
| FY2014 | Dec 31, 2012 | $0 | Feb 4, 2015 |